As of 2024-12-14, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is
-12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value.
With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is
-128.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-12.64 USD
Intrinsic Value
CERE Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
a |
Fair Value |
-12.64 - -12.64 |
-12.64 |
-128.11% |
P/E |
(52.97) - (49.13) |
(57.31) |
-227.5% |
DDM - Stable |
(24.46) - (84.15) |
(54.30) |
-220.8% |
DDM - Multi |
(1.41) - (3.74) |
(2.04) |
-104.5% |
CERE Intrinsic Value - Key Valuation Metrics
Market Cap (mil) |
8,191.26 |
Beta |
1.22 |
Outstanding shares (mil) |
182.19 |
Enterprise Value (mil) |
8,208.75 |
Market risk premium |
4.60% |
Cost of Equity |
8.97% |
Cost of Debt |
5.00% |
WACC |
8.81% |